The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models
Open accessAbstract
Neuritic plaques in the brains are one of the pathological hallmarks of Alzheimer's disease (AD). Amyloid β-protein (Aβ), the central component of neuritic plaques, is derived from β-amyloid precursor protein (APP) after β- and γ-secretase cleavage. The molecular mechanism underlying the pathogenesis of AD is not yet well defined, and there has been no effective treatment for AD. Valproic acid (VPA) is one of the most widely used anticonvulsant and mood-stabilizing agents for treating epilepsy and bipolar disorder. We found that VPA decreased Aβ production by inhibiting GSK-3β–mediated γ-secretase cleavage of APP both in vitro and in vivo. VPA treatment significantly reduced neuritic plaque formation and improved memory deficits in transgenic AD model mice. We also found that early application of VPA was important for alleviating memory deficits of AD model mice. Our study suggests that VPA may be beneficial in the prevention and treatment of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Self-citationA presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain
De Strooper, B., Annaert, W., Cupers, P., Saftig, P., Craessaerts, K., Mumm, J. S., Schroeter, E. H., Schrijvers, V., Wolfe, M. S., Ray, W. J., et al. (1999) · Nature · doi:10.1038/19083 · Cited by 2,100
Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052
Wolfe, M. S., Xia, W., Ostaszewski, B. L., Diehl, T. S., Kimberly, W. T., & Selkoe, D. J. (1999) · Nature · doi:10.1038/19077 · Cited by 1,916
Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F. (1998) · Nature · doi:10.1038/34910 · Cited by 1,818
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388
Recovery of learning and memory is associated with chromatin remodelling
Fischer, A., Sananbenesi, F., Wang, X., Dobbin, M., & Tsai, L.-H. (2007) · Nature · doi:10.1038/nature05772 · Cited by 1,227
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
Phiel, C. J., Wilson, C. A., Lee, V. M.-Y., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,196
BACE1 is the major β-secretase for generation of Aβ peptides by neurons
Cai, H., Wang, Y., McCarthy, D., Wen, H., Borchelt, D. R., Price, D. L., & Wong, P. C. (2001) · Nature Neuroscience · doi:10.1038/85064 · Cited by 1,064
Luo, Y., Bolon, B., Kahn, S., Bennett, B. D., Babu-Khan, S., Denis, P., Fan, W., Kha, H., Zhang, J., Gong, Y., et al. (2001) · Nature Neuroscience · doi:10.1038/85059 · Cited by 1,001
The role of presenilin cofactors in the γ-secretase complex
Takasugi, N., Tomita, T., Hayashi, I., Tsuruoka, M., Niimura, M., Takahashi, Y., Thinakaran, G., & Iwatsubo, T. (2003) · Nature · doi:10.1038/nature01506 · Cited by 867
Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1
Li, Y.-M., Xu, M., Lai, M.-T., Huang, Q., Castro, J. L., DiMuzio-Mower, J., Harrison, T., Lellis, C., Nadin, A., Neduvelil, J. G., et al. (2000) · Nature · doi:10.1038/35015085 · Cited by 866
γ-Secretase Cleavage and Nuclear Localization of ErbB-4 Receptor Tyrosine Kinase
Ni, C.-Y., Murphy, M. P., Golde, T. E., & Carpenter, G. (2001) · Science · doi:10.1126/science.1065412 · Cited by 856
Roberds, S. L. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.12.1317 · Cited by 705
Perucca, E. (2002) · CNS Drugs · doi:10.2165/00023210-200216100-00004 · Cited by 690
A common mechanism of action for three mood-stabilizing drugs
Williams, R. S. B., Cheng, L., Mudge, A. W., & Harwood, A. J. (2002) · Nature · doi:10.1038/417292a · Cited by 618
Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression
Sun, X., He, G., Qing, H., Zhou, W., Dobie, F., Cai, F., Staufenbiel, M., Huang, L. E., & Song, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606298103 · Cited by 605
Self-citationMarambaud, P., Wen, P. H., Dutt, A., Shioi, J., Takashima, A., Siman, R., & Robakis, N. K. (2003) · Cell · doi:10.1016/j.cell.2003.08.008 · Cited by 464
The Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3
Chen, G., Huang, L., Jiang, Y., & Manji, H. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0721327.x · Cited by 438
Presenilins are required for γ-secretase cleavage of β-APP and transmembrane cleavage of Notch-1
Zhang, Z., Nadeau, P., Song, W., Donoviel, D., Yuan, M., Bernstein, A., & Yankner, B. A. (2000) · Nature Cell Biology · doi:10.1038/35017108 · Cited by 409
Self-citationSong, W., Nadeau, P., Yuan, M., Yang, X., Shen, J., & Yankner, B. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6959 · Cited by 362
Self-citationLaVoie, M. J., & Selkoe, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302659200 · Cited by 355
Yuan, P.-X., Huang, L.-D., Jiang, Y.-M., Gutkind, J. S., Manji, H. K., & Chen, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104309200 · Cited by 332
TMP21 is a presenilin complex component that modulates γ-secretase but not ɛ-secretase activity
Chen, F., Hasegawa, H., Schmitt-Ulms, G., Kawarai, T., Bohm, C., Katayama, T., Gu, Y., Sanjo, N., Glista, M., Rogaeva, E., et al. (2006) · Nature · doi:10.1038/nature04667 · Cited by 301
Su, Y., Ryder, J., Li, B., Wu, X., Fox, N., Solenberg, P., Brune, K., Paul, S., Zhou, Y., Liu, F., et al. (2004) · Biochemistry · doi:10.1021/bi035627j · Cited by 296
May, P., Reddy, Y. K., & Herz, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201979200 · Cited by 260
The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and γ-secretase
Six, E., Ndiaye, D., Laâbi, Y., Brou, C., Gupta-Rossi, N., Israël, A., & Logeat, F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1230693100 · Cited by 250
Kim, A. J., Shi, Y., Austin, R. C., & Werstuck, G. H. (2005) · Journal of Cell Science · doi:10.1242/jcs.01562 · Cited by 233
The New Generation of GABA Enhancers: Potential in the Treatment of Epilepsy
Czuczwar, S. J., & Patsalos, P. N. (2001) · CNS Drugs · doi:10.2165/00023210-200115050-00001 · Cited by 209
Zhou, S., Zhou, H., Walian, P. J., & Jap, B. K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502768102 · Cited by 199
Ikeuchi, T., & Sisodia, S. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200711200 · Cited by 196
Degradation of BACE by the ubiquitin‐proteasome pathway
Qing, H., Zhou, W., Christensen, M. A., Sun, X., Tong, Y., & Song, W. (2004) · The FASEB Journal · doi:10.1096/fj.04-1994fje · Cited by 170
Self-citationRyan, K. A., & Pimplikar, S. W. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200505078 · Cited by 168
Valproate Regulates GSK-3-Mediated Axonal Remodeling and Synapsin I Clustering in Developing Neurons
Hall, A. C., Brennan, A., Goold, R. G., Cleverley, K., Lucas, F. R., Gordon-Weeks, P. R., & Salinas, P. C. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1117 · Cited by 166
Kim, D. Y., Ingano, L. A. M., & Kovacs, D. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m210179200 · Cited by 162
Sun, X., He, G., & Song, W. (2006) · The FASEB Journal · doi:10.1096/fj.05-5632com · Cited by 158
Self-citationDistinct transcriptional regulation and function of the human BACE2 and BACE1 genes
Sun, X., Wang, Y., Qing, H., Christensen, M. A., Liu, Y., Zhou, W., Tong, Y., Xiao, C., Huang, Y., Zhang, S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3426com · Cited by 147
Self-citationControl of APP processing and Aβ generation level by BACE1 enzymatic activity and transcription
Li, Y., Zhou, W., Tong, Y., He, G., & Song, W. (2006) · The FASEB Journal · doi:10.1096/fj.05-4986com · Cited by 141
Self-citationA Placebo-Controlled Trial of Valproate for Agitation and Aggression in Alzheimer’s Disease
Herrmann, N., Lanctôt, K. L., Rothenburg, L. S., & Eryavec, G. M. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000097757 · Cited by 113
Eickholt, B. J., Towers, G. J., Ryves, W. J., Eikel, D., Adley, K. E., Ylinen, L. M. J., Chadborn, N., Harwood, A. J., Nau, H., & Williams, R. S. B. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.009308 · Cited by 72
Zhou, S., Zhou, H., Walian, P. J., & Jap, B. K. (2005) · Lawrence Berkeley National Laboratory · Cited by 66
Profenno, L. A., Jakimovich, L. J., Holt, C. J., Porsteinsson, A. P., & Tariot, P. N. (2005) · Current Alzheimer Research · doi:10.2174/156720505774932205 · Cited by 50
Neurodevelopment and Mood Stabilizers
Harwood, A. J. (2003) · Current Molecular Medicine · doi:10.2174/1566524033479672 · Cited by 33
Cited by
Amyloid β-based therapy for Alzheimer’s disease: Challenges, successes and future
Zhang, Y., Chen, H., Li, R., Sterling, K., & Song, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01484-7 · Cited by 988
Self-citationMultiple roles of HDAC inhibition in neurodegenerative conditions
Chuang, D.-M., Leng, Y., Marinova, Z., Kim, H.-J., & Chiu, C.-T. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.06.002 · Cited by 676
Brain-Derived Neurotrophic Factor in Alzheimer’s Disease and Its Pharmaceutical Potential
Gao, L., Zhang, Y., Sterling, K., & Song, W. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00279-0 · Cited by 606
Self-citationMorris Water Maze Test for Learning and Memory Deficits in Alzheimer's Disease Model Mice
Bromley-Brits, K., Deng, Y., & Song, W. (2011) · Journal of Visualized Experiments · doi:10.3791/2920 · Cited by 583
Self-citation(2011) · PubMed Central · Cited by 560
Metadata
- Authors
- Qing, H., He, G., Ly, P. T. T., Fox, C. J., Staufenbiel, M., Cai, F., Zhang, Z., Wei, S., Sun, X., Chen, C.-H., Zhou, W., Wang, K., & Song, W.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2008-10-27
- Volume
- 205
- Issue
- 12
- Pages
- 2781-2789
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2154164205
- Cited by
- 364
- References
- 46
- FWCI
- 11.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.